Search Results

You are looking at 181 - 190 of 2,716 items for :

  • Refine by Access: All x
Clear All
Full access

QIM19-128: Improving Oral Chemotherapy Safety in Adult Neuro-Oncology Clinics

Megan Gershon, Justine Pena, Chamnjot Bains, Sarah Salas, Tresa McGranahan, and Seema Nagpal

implemented a standardized process for OC management. Methods: After review of the literature, we developed a process map for our institution’s practice and performed hazard analysis. We then evaluated the process at 3 other neuro-oncology practices. Based

Full access

QIM119-120: Utilizing Technology to Identify Oncology Patients to Impact Patient Care

Brook Blackmore, Nicole Centers, and Troy Gifford

reports to a tumor site-specific oncology nurse navigator. The impact of this technology was assessed in 3 Hospital Corporation of America (HCA) markets from December 2016–March 2017. Total patient recall, total volume of reports reviewed, navigated

Full access

Electronic Rapid Fitness Assessment: A Novel Tool for Preoperative Evaluation of the Geriatric Oncology Patient

Armin Shahrokni, Amy Tin, Robert J. Downey, Vivian Strong, Sanam Mahmoudzadeh, Manpreet K. Boparai, Sincere McMillan, Andrew Vickers, and Beatriz Korc-Grodzicki

implementation of this GA is to have patients complete it online, using an electronic tablet, with the results automatically collated and reported to the treating clinician. This article reviews our experience with the development and implementation of an

Full access

NCCN Guidelines® Insights: Squamous Cell Skin Cancer, Version 1.2022

Featured Updates to the NCCN Guidelines

Chrysalyne D. Schmults, Rachel Blitzblau, Sumaira Z. Aasi, Murad Alam, James S. Andersen, Brian C. Baumann, Jeremy Bordeaux, Pei-Ling Chen, Robert Chin, Carlo M. Contreras, Dominick DiMaio, Jessica M. Donigan, Jeffrey M. Farma, Karthik Ghosh, Roy C. Grekin, Kelly Harms, Alan L. Ho, Ashley Holder, John Nicholas Lukens, Theresa Medina, Kishwer S. Nehal, Paul Nghiem, Soo Park, Tejesh Patel, Igor Puzanov, Jeffrey Scott, Aleksandar Sekulic, Ashok R. Shaha, Divya Srivastava, William Stebbins, Valencia Thomas, Yaohui G. Xu, Beth McCullough, Mary A. Dwyer, and Mai Q. Nguyen

.0 contact hour (0.1 CEUs) of continuing education credit. UAN: JA4008196-0000-20-015-H01-P All clinicians completing this activity will be issued a certificate of participation. To participate in this journal CE activity: (1) review the educational content

Full access

Summary and Comparison of Myeloid Growth Factor Guidelines in Patients Receiving Cancer Chemotherapy

Gary H. Lyman and Jessica Malone Kleiner

the National Comprehensive Cancer Network on the use of the myeloid growth factors with cancer chemotherapy: a review of the evidence . J Natl Compr Canc Netw 2005 ; 3 : 557 – 571 . 4. Kuderer NM Dale D Crawford J . The morbidity

Full access

Oncology Practice Guidelines: Do They Work?

Rodger J. Winn

review of rigorous evaluations . Lancet 1993 ; 342 : 1317 – 1322 . 4 Smith TJ Hillner BE . Ensuring quality cancer care by the use of clinical practice guidelines and critical pathways . J Clin Oncol 2001 ; 19 : 2886 – 2897 . 5

Full access

Localized Colon Cancer, Version 3.2013

Al B. Benson III, Tanios Bekaii-Saab, Emily Chan, Yi-Jen Chen, Michael A. Choti, Harry S. Cooper, Paul F. Engstrom, Peter C. Enzinger, Marwan G. Fakih, Moon J. Fenton, Charles S. Fuchs, Jean L. Grem, Steven Hunt, Ahmed Kamel, Lucille A. Leong, Edward Lin, Kilian Salerno May, Mary F. Mulcahy, Kate Murphy, Eric Rohren, David P. Ryan, Leonard Saltz, Sunil Sharma, David Shibata, John M. Skibber, William Small Jr, Constantinos T. Sofocleous, Alan P. Venook, Christopher G. Willett, Kristina M. Gregory, and Deborah A. Freedman-Cass

this activity will be issued a certificate of participation. To participate in this journal CE activity: 1) review the learning objectives and author disclosures; 2) study the education content; 3) take the posttest with a 70% minimum passing score and

Full access

NCCN Guidelines® Insights: Myelodysplastic Syndromes, Version 3.2022

Featured Updates to the NCCN Guidelines

Peter L. Greenberg, Richard M. Stone, Aref Al-Kali, John M. Bennett, Uma Borate, Andrew M. Brunner, Wanxing Chai-Ho, Peter Curtin, Carlos M. de Castro, H. Joachim Deeg, Amy E. DeZern, Shira Dinner, Charles Foucar, Karin Gaensler, Guillermo Garcia-Manero, Elizabeth A. Griffiths, David Head, Brian A. Jonas, Sioban Keel, Yazan Madanat, Lori J. Maness, James Mangan, Shannon McCurdy, Christine McMahon, Bhumika Patel, Vishnu V. Reddy, David A. Sallman, Rory Shallis, Paul J. Shami, Swapna Thota, Asya Nina Varshavsky-Yanovsky, Peter Westervelt, Elizabeth Hollinger, Dorothy A. Shead, and Cindy Hochstetler

certificate of participation. To participate in this journal CE activity: (1) review the educational content; (2) take the posttest with a 66% minimum passing score and complete the evaluation at https://education.nccn.org/node/91068 ; and (3) view

Full access

Evolving Use of Androgen Deprivation Therapy in Prostate Cancer Management

James L. Mohler

cancer: a systematic review and meta-analysis . BMC Urol 2014 ; 14 : 9 . 13. Dong Z Wang H Xu M . Intermittent hormone therapy versus continuous hormone therapy for locally advanced prostate cancer: a meta-analysis . Aging Male 2015 ; 18

Full access

Rectal Cancer, Version 2.2015

Al B. Benson III, Alan P. Venook, Tanios Bekaii-Saab, Emily Chan, Yi-Jen Chen, Harry S. Cooper, Paul F. Engstrom, Peter C. Enzinger, Moon J. Fenton, Charles S. Fuchs, Jean L. Grem, Axel Grothey, Howard S. Hochster, Steven Hunt, Ahmed Kamel, Natalie Kirilcuk, Lucille A. Leong, Edward Lin, Wells A. Messersmith, Mary F. Mulcahy, James D. Murphy, Steven Nurkin, Eric Rohren, David P. Ryan, Leonard Saltz, Sunil Sharma, David Shibata, John M. Skibber, Constantinos T. Sofocleous, Elena M. Stoffel, Eden Stotsky-Himelfarb, Christopher G. Willett, Kristina M. Gregory, and Deborah Freedman-Cass

All clinicians completing this activity will be issued a certificate of participation. To participate in this journal CE activity: 1) review the learning objectives and author disclosures; 2) study the education content; 3) take the posttest with a 66